4//SEC Filing
SGX PHARMACEUTICALS, INC. 4
Accession 0001350091-08-000002
CIK 0001125603operating
Filed
Jan 6, 7:00 PM ET
Accepted
Jan 7, 3:14 PM ET
Size
8.8 KB
Accession
0001350091-08-000002
Insider Transaction Report
Form 4
Myers W Todd
CFO
Transactions
- Exercise/Conversion
Restricted Stock Units
2008-01-07−1,562→ 35,938 total→ Common Stock (1,562 underlying) - Sale
Common Stock
2008-01-07$5.15/sh−781$4,022→ 19,534 total - Exercise/Conversion
Common Stock
2008-01-07+1,562→ 20,315 total
Footnotes (3)
- [F1]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 13, 2006.
- [F2]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F3]25% of the restricted stock units vested on December 5, 2006. The remaining restricted stock units vest in equal monthly installments over the subsequent 3 years until December 5, 2009.
Documents
Issuer
SGX PHARMACEUTICALS, INC.
CIK 0001125603
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001125603
Filing Metadata
- Form type
- 4
- Filed
- Jan 6, 7:00 PM ET
- Accepted
- Jan 7, 3:14 PM ET
- Size
- 8.8 KB